Drugs / mercaptoethane sulfonate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00072280 Background | Nov 2004 → Mar 2008 | sarcoma | Children's Oncology Group | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mercaptoethane sulfonate | “MESNA (mercaptoethane sulfonate)” NCT00072280 ↗ |
| Known as | MESNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00072280 ↗ |
| Route | Oral | “Given orally” NCT00072280 ↗ |